Related references
Note: Only part of the references are listed.The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment
Massimo Volpe et al.
CLINICAL SCIENCE (2016)
Role of inflammatory cells in fibroblast activation
Justin Hartupee et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Muscle sympathetic activity in resting and exercising humans with and without heart failure
Catherine F. Notarius et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2015)
Innate Immunity and the Failing Heart The Cytokine Hypothesis Revisited
Douglas L. Mann
CIRCULATION RESEARCH (2015)
The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction
John S. Floras et al.
EUROPEAN HEART JOURNAL (2015)
Autophagy in cardiovascular biology
Sergio Lavandero et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
The Path to an Angiotensin Receptor Antagonist-Neprilysin Inhibitor in the Treatment of Heart Failure
Eugene Braunwald
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Necrotic Myocardial Cells Release Damage-Associated Molecular Patterns That Provoke Fibroblast Activation In Vitro and Trigger Myocardial Inflammation and Fibrosis In Vivo
Weili Zhang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Role of innate and adaptive immune mechanisms in cardiac injury and repair
Slava Epelman et al.
NATURE REVIEWS IMMUNOLOGY (2015)
The pathogenesis of cardiac fibrosis
Ping Kong et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
The Autonomic Nervous System and Heart Failure
Viorel G. Florea et al.
CIRCULATION RESEARCH (2014)
Myofibroblasts: Trust your heart and let fate decide
Jennifer Davis et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Inhibition of brain angiotensin III attenuates sympathetic hyperactivity and cardiac dysfunction in rats post-myocardial infarction
Bing S. Huang et al.
CARDIOVASCULAR RESEARCH (2013)
Adrenergic Nervous System in Heart Failure Pathophysiology and Therapy
Anastasios Lymperopoulos et al.
CIRCULATION RESEARCH (2013)
AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model
Philip W. J. Raake et al.
EUROPEAN HEART JOURNAL (2013)
Calcium cycling proteins and heart failure: mechanisms and therapeutics
Andrew R. Marks
JOURNAL OF CLINICAL INVESTIGATION (2013)
Signaling effectors underlying pathologic growth and remodeling of the heart
Jop H. van Berlo et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1
LaTronya T. McCollum et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Impaired Autophagosome Clearance Contributes to Cardiomyocyte Death in Ischemia/Reperfusion Injury
Xiucui Ma et al.
CIRCULATION (2012)
Myocardial Recovery and the Failing Heart Myth, Magic, or Molecular Target?
Douglas L. Mann et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Reverse remodeling in heart failure-mechanisms and therapeutic opportunities
Norimichi Koitabashi et al.
NATURE REVIEWS CARDIOLOGY (2012)
Heart Failure 1 In search of new therapeutic targets and strategies for heart failure: recent advances in basic science
Ajay M. Shah et al.
LANCET (2011)
Cell Death in the Pathogenesis of Heart Disease: Mechanisms and Significance
Russell S. Whelan et al.
ANNUAL REVIEW OF PHYSIOLOGY (2010)
Differential Cardiac Remodeling in Preload Versus Afterload
Karl Toischer et al.
CIRCULATION (2010)
Autophagy and the Integrated Stress Response
Guido Kroemer et al.
MOLECULAR CELL (2010)
Aldosterone 'escape' vs 'breakthrough'
Robert W. Schrier
NATURE REVIEWS NEPHROLOGY (2010)
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
G. Kroemer et al.
CELL DEATH AND DIFFERENTIATION (2009)
Myocardial Adeno-Associated Virus Serotype 6-βARKct Gene Therapy Improves Cardiac Function and Normalizes the Neurohormonal Axis in Chronic Heart Failure
Giuseppe Rengo et al.
CIRCULATION (2009)
Combined Increased Chemosensitivity to Hypoxia and Hypercapnia as a Prognosticator in Heart Failure
Alberto Giannoni et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Return to the fetal gene program protects the stressed heart: a strong hypothesis
Mitra Rajabi et al.
HEART FAILURE REVIEWS (2007)
TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways
Sandra B. Haudek et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The incidence and implications of aldosterone breakthrough
Andrew S. Bomback et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2007)
GRKs and β-arrestins:: roles in receptor silencing, trafficking and signaling
Eric Reiter et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2006)
Pathophysiology of water and sodium retention: edematous states with normal kidney function
MR Bekheirnia et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications
A Clerico et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Left ventricular size and shape: Determinants of mechanical signal transduction pathways
DL Mann
HEART FAILURE REVIEWS (2005)
Mechanisms and models in heart failure the biomechanical model and beyond
DL Mann et al.
CIRCULATION (2005)
Angiotensin IV activates the nuclear transcription factor-κB and related proinflammatory genes in vascular smooth muscle cells
V Esteban et al.
CIRCULATION RESEARCH (2005)
Mechanisms of Disease: beta-adrenergic receptors - alterations in signal transduction and pharmacogenomics in heart failure
DS Feldman et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2005)
Modification of myosin protein and gene expression in failing hearts due to myocardial infarction by enalapril or losartan
JW Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2004)
β-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure
S Reiken et al.
CIRCULATION (2003)
Myocytes die by multiple mechanisms in failing human hearts
S Kostin et al.
CIRCULATION RESEARCH (2003)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Effects of different angiotensins during acute, double blockade of the renin system in conscious dogs
C Wamberg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice
EEJM Creemers et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents
BD Lowes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Seven-transmembrane-spanning receptors and heart function
HA Rockman et al.
NATURE (2002)
β-Adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure
S Reiken et al.
CIRCULATION (2001)
Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure
PP Ponikowski et al.
CIRCULATION (2001)
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
VB Harding et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure
JD Port et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2001)
Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure - Insights from the Randomized Aldactone Evaluation Study (RALES)
F Zannad et al.
CIRCULATION (2000)
Disruption of the myocardial extracellular matrix leads to cardiac dysfunction
HE Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease
CG Brilla et al.
CIRCULATION (2000)
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
A Ducharme et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): Defective regulation in failing hearts
SO Marx et al.
CELL (2000)
Myocardial-directed overexpression of the human β1-adrenergic receptor in transgenic mice
JD Bisognano et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
The role of the cytoskeleton in heart failure
S Hein et al.
CARDIOVASCULAR RESEARCH (2000)
Share Paper
